×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
Yahoo Finance
In RAS-mutated mCRC, clinical data from ONSEMBLE trial, and preclinical data presented at AACR, demonstrated strong efficacy signal in bev...
6 hours ago
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance
Cardiff Oncology (CRDF) delivered earnings and revenue surprises of 12% and 86.36%, respectively, for the quarter ended March 2024.
4 hours ago
Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
mypanhandle.com
Management will hold a conference call on Thursday, May 2 at 4:30 p.m. ET/1:30 p.m. PT -. SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE)...
5 days ago
Cardiff Oncology Announces Publication of Data from Phase 1b study in second-line KRAS-mutated mCRC in Clinical ...
PR Newswire
The publication underscores the safety profile of onvansertib when combined with the standard-of-care (SoC) chemotherapy+bevacizumab. The...
3 months ago
Cardiff Oncology: Why The Bulls Are Winning Right Now (Rating Upgrade) (NASDAQ:CRDF)
Seeking Alpha
Cardiff is developing a drug for colorectal and pancreatic cancer, showing promise and conducting clinical trials for efficacy.
1 month ago
Cardiff Oncology (CRDF) Scheduled to Post Earnings on Thursday
MarketBeat
Cardiff Oncology (NASDAQ:CRDF) will be releasing earnings after the market closes on Thursday, May 2, Zacks reports.
1 day ago
Cardiff Oncology to Present at the 35th Annual Piper Sandler Healthcare Conference
PR Newswire
Cardiff Oncology is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel...
5 months ago
Cardiff Oncology (CRDF) Is a Great Choice for 'Trend' Investors, Here's Why
Yahoo Finance
Cardiff Oncology (CRDF) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a...
1 month ago
Cardiff Oncology (CRDF) Moves 20.5% Higher: Will This Strength Last?
Yahoo Finance
Cardiff Oncology (CRDF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions...
1 month ago
Cardiff Oncology Inc (CRDF) Reports Q4 and Full Year 2023 Financial Results
Yahoo Finance
Cardiff Oncology's financial results reflect a company in the midst of advancing its clinical programs, with a focus on its lead drug candidate,...
2 months ago